Skip to content
10-Q

Quarterly Report

Repare Therapeutics Inc.

0000950170-25-105468

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 42.96M sh
Shares Diluted Q2 2025 · Jun 30, 2025 42.92M sh
Shares Diluted Q2 2025 · Jun 30, 2025 42.76M sh
Shares Diluted Q2 2025 · Jun 30, 2024 42.45M sh
Shares Diluted Q2 2025 · Jun 30, 2024 42.34M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$45.48M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$18.58M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $67.66M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $84.72M
Stockholders Equity Q2 2025 · Jun 30, 2025 $110.41M
Stockholders Equity Q2 2025 · Mar 31, 2025 $125.1M
Stockholders Equity Q2 2025 · Dec 31, 2024 $151.13M
Stockholders Equity Q2 2025 · Jun 30, 2024 $203.68M
Stockholders Equity Q2 2025 · Mar 31, 2024 $231.95M
Stockholders Equity Q2 2025 · Dec 31, 2023 $212.08M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.09M
Current Liabilities Q2 2025 · Dec 31, 2024 $25.29M
Total Liabilities Q2 2025 · Jun 30, 2025 $20.09M
Total Liabilities Q2 2025 · Dec 31, 2024 $25.38M
Current Assets Q2 2025 · Jun 30, 2025 $126.57M
Current Assets Q2 2025 · Dec 31, 2024 $171.15M
Total Assets Q2 2025 · Jun 30, 2025 $130.49M
Total Assets Q2 2025 · Dec 31, 2024 $176.51M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.39
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.09
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.82
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.51
Eps Basic Q2 2025 · Jun 30, 2025 −$0.39
Eps Basic Q2 2025 · Jun 30, 2025 −$1.09
Eps Basic Q2 2025 · Jun 30, 2024 −$0.82
Eps Basic Q2 2025 · Jun 30, 2024 −$0.51
Sga Expense Q2 2025 · Jun 30, 2025 $6.03M
Sga Expense Q2 2025 · Jun 30, 2025 $13.68M
Sga Expense Q2 2025 · Jun 30, 2024 $8.32M
Sga Expense Q2 2025 · Jun 30, 2024 $16.94M
Rd Expense Q2 2025 · Jun 30, 2025 $14.28M
Rd Expense Q2 2025 · Jun 30, 2025 $34.55M
Rd Expense Q2 2025 · Jun 30, 2024 $30.08M
Rd Expense Q2 2025 · Jun 30, 2024 $63.05M
Net Income Q2 2025 · Jun 30, 2025 −$16.74M
Net Income Q2 2025 · Jun 30, 2025 −$46.79M
Net Income Q2 2025 · Jun 30, 2024 −$34.77M
Net Income Q2 2025 · Jun 30, 2024 −$21.61M
Operating Income Q2 2025 · Jun 30, 2025 −$17.78M
Operating Income Q2 2025 · Jun 30, 2025 −$48.97M
Operating Income Q2 2025 · Jun 30, 2024 −$37.32M
Operating Income Q2 2025 · Jun 30, 2024 −$26.5M